Results 1 to 10 of about 159,541 (159)

Upper Gastrointestinal Cancer and Liver Cirrhosis [PDF]

open access: yesCancers, 2022
The extended scope of upper gastrointestinal cancer can include esophageal cancer, gastric cancer and pancreatic cancer. A higher incidence rate of gastric cancer and esophageal cancer in patients with liver cirrhosis has been reported. It is attributable to four possible causes which exist in cirrhotic patients, including a higher prevalence of ...
Kuo-Shyang Jeng   +2 more
exaly   +4 more sources

Upper Gastrointestinal Cancer Surveillance in Lynch Syndrome [PDF]

open access: yesCancers, 2022
Lynch syndrome is a common hereditary cancer predisposition syndrome associated with increased digestive cancer risk including colorectal, gastric, and duodenal cancers. While colorectal cancer surveillance is widely accepted to be an important part of a comprehensive Lynch syndrome risk management plan, the use of upper gastrointestinal cancer ...
Bryson Katona   +2 more
exaly   +3 more sources

The Role of Chemerin in Upper Gastrointestinal Cancer. [PDF]

open access: yesMetabolites
Background/Objectives: Chemerin, which is a multifunctional cytokine and adipokine, has been implicated in inflammatory and metabolic processes and might play a role in upper gastrointes-tinal (GI) malignancies, particularly gastric and esophageal cancer.
Mylonakis A   +10 more
europepmc   +5 more sources

Upper gastrointestinal bleeding as a warning sign of gastrointestinal cancer

open access: yesPreventive Medicine Reports
Background: Upper gastrointestinal bleeding (UGIB) is a prevalent etiology for hospital admissions on a global scale. However, the significance of UGIB as a warning sign of gastrointestinal (GI) cancer is frequently disregarded due to its uncommon and ...
Haozhe Cui   +3 more
doaj   +3 more sources

Management of upper gastrointestinal cancers [PDF]

open access: yesQuality in Health Care, 2001
This paper is an edited version of Effective Health Care volume 6 number 4 (December 2000), which deals with the management of cancers of the oesophagus, stomach and pancreas. It summarises systematic reviews undertaken to inform Improving Outcomes in Upper Gastro-intestinal Cancers .1 These publications form part of a series providing guidance on NHS ...
A, Melville   +3 more
openaire   +2 more sources

Adrenal insufficiency after curative-intent gastric cancer treatment: a case report

open access: yesJournal of Medical Case Reports, 2023
Background Adrenal insufficiency is a life-threatening condition, and advanced gastric cancer is associated with very poor prognosis. Adrenalectomy and/or metastatic invasion of the adrenal glands can cause primary adrenal insufficiency, which in turn ...
Johan Hardvik Åkerström   +1 more
doaj   +1 more source

Adjuvant SOX chemotherapy versus concurrent chemoradiotherapy after D2 radical resection of locally advanced esophagogastric junction (EGJ) adenocarcinoma: study protocol for a randomized phase III trial (ARTEG)

open access: yesTrials, 2021
Background Survival benefit of adjuvant radiotherapy for locally advanced gastric cancer following gastrectomy plus D2 lymphadenectomy has always been controversial.
Jinwen Shen   +11 more
doaj   +1 more source

A literature review on the potential clinical implications of streptococci in gastric cancer

open access: yesFrontiers in Microbiology, 2022
Streptococcus is widely found in nature and the human body, and most species are not pathogenic. In recent years, studies have found that Streptococcus is associated with gastric cancer.
Mengli Zi   +18 more
doaj   +1 more source

CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia

open access: yesBMC Gastroenterology, 2022
Background Intestinal metaplasia (IM) is considered a key pivot point in the Correa model of gastric cancer (GC). It is histologically subtyped into the complete and incomplete subtypes, the latter being associated with a greater risk of progression ...
Athanasios Koulis   +6 more
doaj   +1 more source

Trametes robiniophila Murr Sensitizes Gastric Cancer Cells to 5-Fluorouracil by Modulating Tumor Microenvironment

open access: yesFrontiers in Pharmacology, 2022
Trametes robiniophila Murr (TRM) is a traditional Chinese medicine which has been used in clinics for enhancing immunity and improving the efficacy of chemotherapy. However, the mechanisms of action of TRM are unknown.
Jing-Li Xu   +22 more
doaj   +1 more source

Home - About - Disclaimer - Privacy